Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Change in Receivables (2016 - 2023)

Historic Change in Receivables for Palisade Bio (PALI) over the last 13 years, with Q1 2023 value amounting to $250000.0.

  • Palisade Bio's Change in Receivables changed N/A to $250000.0 in Q1 2023 from the same period last year, while for Mar 2024 it was $334000.0, marking a year-over-year increase of 2145.45%. This contributed to the annual value of -$84000.0 for FY2021, which is 24237.29% down from last year.
  • According to the latest figures from Q1 2023, Palisade Bio's Change in Receivables is $250000.0.
  • Over the past 5 years, Palisade Bio's Change in Receivables peaked at $250000.0 during Q1 2023, and registered a low of -$108751.0 during Q3 2019.
  • Its 5-year average for Change in Receivables is -$1916.1, with a median of -$32545.0 in 2019.
  • As far as peak fluctuations go, Palisade Bio's Change in Receivables surged by 18110.26% in 2020, and later plummeted by 277804.88% in 2021.
  • Palisade Bio's Change in Receivables (Quarter) stood at -$40090.0 in 2019, then soared by 114.97% to $6000.0 in 2020, then crashed by 1083.33% to -$59000.0 in 2021, then skyrocketed by 242.37% to $84000.0 in 2022, then surged by 197.62% to $250000.0 in 2023.
  • Its Change in Receivables stands at $250000.0 for Q1 2023, versus $84000.0 for Q4 2022 and -$59000.0 for Q3 2021.